Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (US FDA) to manufacture and market Zaleplon capsules 5mg and 10mg.

Zaleplon capsules are the generic equivalent of King Pharmaceutical's Sonata capsules, which are indicated for the treatment of insomnia. Aurobindo is in the first line of generics and got the US FDA approval on the very first day post the expiry of the relevant patent and has already launched the product in the US market.